Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
;
Nicola
Dryden
;
Sarah
Maguire
;
Daniela
Novo
;
Eleni
Perrakis
;
Nichola
Johnson
;
Maya
Ghoussaini
;
John L
Hopper
;
Melissa C
Southey
;
+206 more...
Carmel
Apicella
;
Jennifer
Stone
;
Marjanka K
Schmidt
;
Annegien
Broeks
;
Laura J
Van't Veer
;
Frans B
Hogervorst
;
Peter A
Fasching
;
Lothar
Haeberle
;
Arif B
Ekici
;
Matthias W
Beckmann
;
Lorna
Gibson
;
Zoe
Aitken
;
Helen
Warren
;
Elinor
Sawyer
;
Ian
Tomlinson
;
Michael J
Kerin
;
Nicola
Miller
;
Barbara
Burwinkel
;
Frederik
Marme
;
Andreas
Schneeweiss
;
Chistof
Sohn
;
Pascal
Guénel
;
Thérèse
Truong
;
Emilie
Cordina-Duverger
;
Marie
Sanchez
;
Stig E
Bojesen
;
Børge G
Nordestgaard
;
Sune F
Nielsen
;
Henrik
Flyger
;
Javier
Benitez
;
Maria Pilar
Zamora
;
Jose Ignacio
Arias Perez
;
Primitiva
Menéndez
;
Hoda
Anton-Culver
;
Susan L
Neuhausen
;
Hermann
Brenner
;
Aida Karina
Dieffenbach
;
Volker
Arndt
;
Christa
Stegmaier
;
Ute
Hamann
;
Hiltrud
Brauch
;
Christina
Justenhoven
;
Thomas
Brüning
;
Yon-Dschun
Ko
;
Heli
Nevanlinna
;
Kristiina
Aittomäki
;
Carl
Blomqvist
;
Sofia
Khan
;
Natalia
Bogdanova
;
Thilo
Dörk
;
Annika
Lindblom
;
Sara
Margolin
;
Arto
Mannermaa
;
Vesa
Kataja
;
Veli-Matti
Kosma
;
Jaana M
Hartikainen
;
Georgia
Chenevix-Trench
;
Jonathan
Beesley
;
Diether
Lambrechts
;
Matthieu
Moisse
;
Guiseppe
Floris
;
Benoit
Beuselinck
;
Jenny
Chang-Claude
;
Anja
Rudolph
;
Petra
Seibold
;
Dieter
Flesch-Janys
;
Paolo
Radice
;
Paolo
Peterlongo
;
Bernard
Peissel
;
Valeria
Pensotti
;
Fergus J
Couch
;
Janet E
Olson
;
Seth
Slettedahl
;
Celine
Vachon
;
Graham G
Giles
;
Roger L
Milne
;
Catriona
McLean
;
Christopher A
Haiman
;
Brian E
Henderson
;
Fredrick
Schumacher
;
Loic
Le Marchand
;
Jacques
Simard
;
Mark S
Goldberg
;
France
Labrèche
;
Martine
Dumont
;
Vessela
Kristensen
;
Grethe Grenaker
Alnæs
;
Silje
Nord
;
Anne-Lise
Borresen-Dale
;
Wei
Zheng
;
Sandra
Deming-Halverson
;
Martha
Shrubsole
;
Jirong
Long
;
Robert
Winqvist
;
Katri
Pylkäs
;
Arja
Jukkola-Vuorinen
;
Mervi
Grip
;
Irene L
Andrulis
;
Julia A
Knight
;
Gord
Glendon
;
Sandrine
Tchatchou
;
Peter
Devilee
;
Robertus AEM
Tollenaar
;
Caroline M
Seynaeve
;
Christi J
Van Asperen
;
Montserrat
Garcia-Closas
;
Jonine
Figueroa
;
Stephen J
Chanock
;
Jolanta
Lissowska
;
Kamila
Czene
;
Hatef
Darabi
;
Mikael
Eriksson
;
Daniel
Klevebring
;
Maartje J
Hooning
;
Antoinette
Hollestelle
;
Carolien HM
van Deurzen
;
Mieke
Kriege
;
Per
Hall
;
Jingmei
Li
;
Jianjun
Liu
;
Keith
Humphreys
;
Angela
Cox
;
Simon S
Cross
;
Malcolm WR
Reed
;
Paul DP
Pharoah
;
Alison M
Dunning
;
Mitul
Shah
;
Barbara J
Perkins
;
Anna
Jakubowska
;
Jan
Lubinski
;
Katarzyna
Jaworska-Bieniek
;
Katarzyna
Durda
;
Alan
Ashworth
;
Anthony
Swerdlow
;
Michael
Jones
;
Minouk J
Schoemaker
;
Alfons
Meindl
;
Rita K
Schmutzler
;
Curtis
Olswold
;
Susan
Slager
;
Amanda E
Toland
;
Drakoulis
Yannoukakos
;
Kenneth
Muir
;
Artitaya
Lophatananon
;
Sarah
Stewart-Brown
;
Pornthep
Siriwanarangsan
;
Keitaro
Matsuo
;
Hidema
Ito
;
Hiroji
Iwata
;
Junko
Ishiguro
;
Anna H
Wu
;
Chiu-Chen
Tseng
;
David
Van Den Berg
;
Daniel O
Stram
;
Soo Hwang
Teo
;
Cheng Har
Yip
;
Peter
Kang
;
Mohammad Kamran
Ikram
;
Xiao-Ou
Shu
;
Wei
Lu
;
Yu-Tang
Gao
;
Hui
Cai
;
Daehee
Kang
;
Ji-Yeob
Choi
;
Sue K
Park
;
Dong-Young
Noh
;
Mikael
Hartman
;
Hui
Miao
;
Wei Yen
Lim
;
Soo Chin
Lee
;
Suleeporn
Sangrajrang
;
Valerie
Gaborieau
;
Paul
Brennan
;
James
Mckay
;
Pei-Ei
Wu
;
Ming-Feng
Hou
;
Jyh-Cherng
Yu
;
Chen-Yang
Shen
;
William
Blot
;
Qiuyin
Cai
;
Lisa B
Signorello
;
Craig
Luccarini
;
Caroline
Bayes
;
Shahana
Ahmed
;
Mel
Maranian
;
Catherine S
Healey
;
Anna
González-Neira
;
Guillermo
Pita
;
M Rosario
Alonso
;
Nuria
Álvarez
;
Daniel
Herrero
;
Daniel C
Tessier
;
Daniel
Vincent
;
Francois
Bacot
;
David J
Hunter
;
Sara
Lindstrom
;
Joe
Dennis
;
Kyriaki
Michailidou
;
Manjeet K
Bolla
;
Douglas F
Easton
;
Isabel
dos Santos Silva
;
Olivia
Fletcher
;
Julian
Peto
;
GENICA Network
;
kConFab Investigators
;
Australian Ovarian Cancer Study Group
;
(2015)
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Human molecular genetics, 24 (10).
pp. 2966-2984.
ISSN 0964-6906
DOI: 10.1093/hmg/ddv035
We recently identified a novel susceptibility variant, rs865686, for estrogen-receptor positive breast cancer at 9q31.2. Here, we report a fine-mapping analysis of the 9q31.2 susceptibility locus using 43 160 cases and 42 600 controls of European ancestry ascertained from 52 studies and a further 5795 cases and 6624 controls of Asian ancestry from nine studies. Single nucleotide polymorphism (SNP) rs676256 was most strongly associated with risk in Europeans (odds ratios [OR] = 0.90 [0.88-0.92]; P-value = 1.58 × 10(-25)). This SNP is one of a cluster of highly correlated variants, including rs865686, that spans ∼14.5 kb. We identified two additional independent association signals demarcated by SNPs rs10816625 (OR = 1.12 [1.08-1.17]; P-value = 7.89 × 10(-09)) and rs13294895 (OR = 1.09 [1.06-1.12]; P-value = 2.97 × 10(-11)). SNP rs10816625, but not rs13294895, was also associated with risk of breast cancer in Asian individuals (OR = 1.12 [1.06-1.18]; P-value = 2.77 × 10(-05)). Functional genomic annotation using data derived from breast cancer cell-line models indicates that these SNPs localise to putative enhancer elements that bind known drivers of hormone-dependent breast cancer, including ER-α, FOXA1 and GATA-3. In vitro analyses indicate that rs10816625 and rs13294895 have allele-specific effects on enhancer activity and suggest chromatin interactions with the KLF4 gene locus. These results demonstrate the power of dense genotyping in large studies to identify independent susceptibility variants. Analysis of associations using subjects with different ancestry, combined with bioinformatic and genomic characterisation, can provide strong evidence for the likely causative alleles and their functional basis.
-
picture_as_pdf - ddv035.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0